Treating Non-Squamous NSCLC with High Levels of PD-L1

Treating Non-Squamous NSCLC with High Levels of PD-L1

User Photo
obr

1 year
109 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ravi Salgia, MD, Professor and Chair, Department of Medical Oncology and Therapeutics Research, Associate Director for Clinical Sciences, Arthur and Rosalie Kaplan Endowed Chair in Medical Oncology, City of Hope on treating non-squamous, non-small cell lung cancer (NSCLC) patients who express high levels of PD-L1.
Up Next Autoplay